Cliff Asness's PRME Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 414,211 shares of Prime Medicine, Inc. (PRME) worth $2.29 M, representing 0.00% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Cliff Asness has maintained this position in PRME for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 227,749 shares. Largest reduction occurred in Q3 2024, reducing 34,268 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Prime Medicine (PRME) Holding Value Over Time
Track share changes against reported price movement
Quarterly Prime Medicine (PRME) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2024 | +34,268 | New Buy | 34,268 | $5.14 |
| Q3 2024 | -34,268 | Sold Out | 0 | $0.00 |
| Q4 2024 | +16,046 | New Buy | 16,046 | $2.92 |
| Q1 2025 | +227,749 | Add 1419.35% | 243,795 | $1.99 |
| Q2 2025 | +180,560 | Add 74.06% | 424,355 | $2.47 |
| Q3 2025 | -10,144 | Reduce 2.39% | 414,211 | $5.54 |
Cliff Asness's Prime Medicine Investment FAQs
Cliff Asness first purchased Prime Medicine, Inc. (PRME) in Q2 2024, acquiring 34,268 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Prime Medicine, Inc. (PRME) for 6 quarters since Q2 2024.
Cliff Asness's largest addition to Prime Medicine, Inc. (PRME) was in Q1 2025, adding 243,795 shares worth $485,152.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 414,211 shares of Prime Medicine, Inc. (PRME), valued at approximately $2.29 M.
As of the Q3 2025 filing, Prime Medicine, Inc. (PRME) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Prime Medicine, Inc. (PRME) was 424,355 shares, as reported at the end of Q2 2025.